Literature DB >> 31397084

Rehabilitation across the lifespan for individuals with arthrogryposis.

Lisa V Wagner1, J Suzanne Cherry1, Bonita J Sawatzky2, Alicja Fąfara3, Caroline Elfassy4, Marie Eriksson5, Kathleen Montpetit4, Tricia Bucci1, Maureen Donohoe6.   

Abstract

Arthrogryposis multiplex congenita (AMC) can be a perplexing diagnosis that consists of limited range of motion (ROM) and decreased muscle strength in multiple joints. The person with AMC often possesses a certain tenacity and "spunk" that assists them with adjusting and adapting to the realities of daily life. The rehabilitation process assists the individual with AMC in achieving and maintaining the maximal active and passive range of motion and strength in order to participate in activities of daily living (ADL) throughout the developmental stages. The result of this life-long process is greatly impacted by collaboration among the multidisciplinary teams. Ultimately, rehabilitation should focus on three levels of treatment: (a) body structure, (b) activity, and (c) participation. This article describes rehabilitation across the lifespan-focusing on the therapeutic needs in the infant, toddler, school age and teenage/adult years-while also highlighting opportunities for improvement.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  activities of daily living; arthrogryposis multiplex congenita; orthotics; range of motion; rehabilitation

Mesh:

Year:  2019        PMID: 31397084     DOI: 10.1002/ajmg.c.31729

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  1 in total

1.  Using Telerehabilitation to Deliver a Home Exercise Program to Youth With Arthrogryposis: Single Cohort Pilot Study.

Authors:  Marianne Gagnon; Gabriela Marino Merlo; Rita Yap; Jessica Collins; Caroline Elfassy; Bonita Sawatzky; Jacquelyn Marsh; Reggie Hamdy; Louis-Nicolas Veilleux; Noémi Dahan-Oliel
Journal:  J Med Internet Res       Date:  2021-07-06       Impact factor: 5.428

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.